{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:06:36Z","timestamp":1791223596762,"version":"4.1.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,6,19]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>A functional demonstration of the oncogenic role of mutated EZH2 in a mouse model is presented. The global effects of mutated EZH2 on expression and epigenome have been characterized.<\/jats:p>","DOI":"10.1182\/blood-2012-12-473439","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T23:54:02Z","timestamp":1399420442000},"page":"3914-3924","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":84,"title":["A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis"],"prefix":"10.1182","volume":"123","author":[{"given":"Tobias","family":"Berg","sequence":"first","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Medicine, Hematology and Oncology, University of Frankfurt, Frankfurt\/Main, Germany;"},{"name":"German Cancer Consortium (DKTK), Heidelberg, Germany;"},{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Thoene","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Yap","sequence":"additional","affiliation":[{"name":"Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracee","family":"Wee","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Schoeler","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada;"},{"name":"Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany;"},{"name":"Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patty","family":"Rosten","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Lim","sequence":"additional","affiliation":[{"name":"Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Bilenky","sequence":"additional","affiliation":[{"name":"Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Mungall","sequence":"additional","affiliation":[{"name":"Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Oellerich","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology and Oncology, University of Frankfurt, Frankfurt\/Main, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Lee","sequence":"additional","affiliation":[{"name":"Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courteney K.","family":"Lai","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Umlandt","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisa","family":"Salmi","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Chang","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Yue","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lai","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-W. Grace","family":"Cheng","sequence":"additional","affiliation":[{"name":"Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Morin","sequence":"additional","affiliation":[{"name":"Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;"},{"name":"Simon Fraser University, Burnaby, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hirst","sequence":"additional","affiliation":[{"name":"Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Microbiology and Immunology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Serve","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology and Oncology, University of Frankfurt, Frankfurt\/Main, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Marra","sequence":"additional","affiliation":[{"name":"Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg B.","family":"Morin","sequence":"additional","affiliation":[{"name":"Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy D.","family":"Gascoyne","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada;"},{"name":"Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"Aparicio","sequence":"additional","affiliation":[{"name":"Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Keith","family":"Humphries","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada;"},{"name":"Department of Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5595","key":"2019111820141320700_B1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing.","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"issue":"3","key":"2019111820141320700_B2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.stem.2010.08.002","article-title":"Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer.","volume":"7","author":"Sauvageau","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"13","key":"2019111820141320700_B3","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/MCB.21.13.4330-4336.2001","article-title":"The polycomb-group gene Ezh2 is required for early mouse development.","volume":"21","author":"O\u2019Carroll","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2019111820141320700_B4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.molcel.2008.11.004","article-title":"Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms.","volume":"32","author":"Margueron","year":"2008","journal-title":"Mol Cell"},{"issue":"2","key":"2019111820141320700_B5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ni876","article-title":"Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement.","volume":"4","author":"Su","year":"2003","journal-title":"Nat Immunol"},{"issue":"1","key":"2019111820141320700_B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.164.1.1","article-title":"Cutting edge: polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers.","volume":"164","author":"Raaphorst","year":"2000","journal-title":"J Immunol"},{"issue":"7","key":"2019111820141320700_B7","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/eji.200424985","article-title":"Distinct expression patterns of polycomb oncoproteins and their binding partners during the germinal center reaction.","volume":"34","author":"van Galen","year":"2004","journal-title":"Eur J Immunol"},{"issue":"6907","key":"2019111820141320700_B8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer.","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"issue":"5","key":"2019111820141320700_B9","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1182\/blood-2005-09-3585","article-title":"The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion.","volume":"107","author":"Kamminga","year":"2006","journal-title":"Blood"},{"key":"2019111820141320700_B10","first-page":"623","article-title":"Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease.","volume-title":"Nature Commun","author":"Herrera-Merchan","year":"2012"},{"issue":"24","key":"2019111820141320700_B11","doi-asserted-by":"crossref","first-page":"9211","DOI":"10.1158\/0008-5472.CAN-09-1622","article-title":"EZH2 is essential for glioblastoma cancer stem cell maintenance.","volume":"69","author":"Suv\u00e0","year":"2009","journal-title":"Cancer Res"},{"issue":"12","key":"2019111820141320700_B12","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1182\/blood.V97.12.3896","article-title":"Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma.","volume":"97","author":"van Kemenade","year":"2001","journal-title":"Blood"},{"issue":"3","key":"2019111820141320700_B13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0002-9440(10)63175-6","article-title":"Unique polycomb gene expression pattern in Hodgkin\u2019s lymphoma and Hodgkin\u2019s lymphoma-derived cell lines.","volume":"164","author":"Dukers","year":"2004","journal-title":"Am J Pathol"},{"issue":"3","key":"2019111820141320700_B14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0002-9440(10)64583-X","article-title":"Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin\u2019s disease.","volume":"157","author":"Raaphorst","year":"2000","journal-title":"Am J Pathol"},{"issue":"2","key":"2019111820141320700_B15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"issue":"8","key":"2019111820141320700_B16","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1073\/pnas.1116418109","article-title":"Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).","volume":"109","author":"McCabe","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7337","key":"2019111820141320700_B17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma.","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"issue":"7360","key":"2019111820141320700_B18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"49","key":"2019111820141320700_B19","doi-asserted-by":"crossref","first-page":"20980","DOI":"10.1073\/pnas.1012525107","article-title":"Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas.","volume":"107","author":"Sneeringer","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2019111820141320700_B20","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood-2010-11-321208","article-title":"Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.","volume":"117","author":"Yap","year":"2011","journal-title":"Blood"},{"issue":"7427","key":"2019111820141320700_B21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"issue":"11","key":"2019111820141320700_B22","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nchembio.1084","article-title":"A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells.","volume":"8","author":"Knutson","year":"2012","journal-title":"Nat Chem Biol"},{"issue":"6","key":"2019111820141320700_B23","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1021\/cb400133j","article-title":"An orally bioavailable chemical probe of the lysine methyltransferases EZH2 and EZH1.","volume":"8","author":"Konze","year":"2013","journal-title":"ACS Chem Biol"},{"issue":"52","key":"2019111820141320700_B24","doi-asserted-by":"crossref","first-page":"21360","DOI":"10.1073\/pnas.1210371110","article-title":"Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation.","volume":"109","author":"Qi","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2019111820141320700_B25","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1182\/blood-2002-08-2484","article-title":"Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.","volume":"101","author":"Pineault","year":"2003","journal-title":"Blood"},{"issue":"10","key":"2019111820141320700_B26","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2019111820141320700_B27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1074-7613(00)80070-9","article-title":"Distinct signals mediate maturation and allelic exclusion in lymphocyte progenitors.","volume":"10","author":"Iritani","year":"1999","journal-title":"Immunity"},{"issue":"12","key":"2019111820141320700_B28","doi-asserted-by":"crossref","first-page":"e28585","DOI":"10.1371\/journal.pone.0028585","article-title":"EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas.","volume":"6","author":"Ryan","year":"2011","journal-title":"PLoS ONE"},{"issue":"24","key":"2019111820141320700_B29","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1182\/blood-2010-04-280149","article-title":"EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis.","volume":"116","author":"Velichutina","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2019111820141320700_B30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","article-title":"EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation.","volume":"23","author":"B\u00e9guelin","year":"2013","journal-title":"Cancer Cell"},{"issue":"11","key":"2019111820141320700_B31","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"issue":"suppl 36","key":"2019111820141320700_B32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jcb.1093","article-title":"Differential expression of human Polycomb group proteins in various tissues and cell types.","volume":"81","author":"Gunster","year":"2001","journal-title":"J Cell Biochem"},{"issue":"20","key":"2019111820141320700_B33","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","article-title":"EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.","volume":"22","author":"Bracken","year":"2003","journal-title":"EMBO J"},{"issue":"22","key":"2019111820141320700_B34","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2012-08-450494","article-title":"EZH2 overexpression in natural killer\/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity.","volume":"121","author":"Yan","year":"2013","journal-title":"Blood"},{"issue":"11","key":"2019111820141320700_B35","first-page":"3161","article-title":"bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis.","volume":"8","author":"Haupt","year":"1993","journal-title":"Oncogene"},{"issue":"20","key":"2019111820141320700_B36","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1101\/gad.13.20.2678","article-title":"Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a\/ARF.","volume":"13","author":"Jacobs","year":"1999","journal-title":"Genes Dev"},{"issue":"13","key":"2019111820141320700_B37","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1073\/pnas.0608721104","article-title":"Role of the chromobox protein CBX7 in lymphomagenesis.","volume":"104","author":"Scott","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"2019111820141320700_B38","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1182\/blood-2013-02-484055","article-title":"Polycomb repressive complex 2 (PRC2) suppresses E\u03bc-myc lymphoma.","volume":"122","author":"Lee","year":"2013","journal-title":"Blood"},{"issue":"9","key":"2019111820141320700_B39","doi-asserted-by":"crossref","first-page":"E1774","DOI":"10.1210\/jc.2012-1743","article-title":"Identification of somatic mutations in parathyroid tumors using whole-exome sequencing.","volume":"97","author":"Cromer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2019111820141320700_B40","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"issue":"8","key":"2019111820141320700_B41","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ng.620","article-title":"Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.","volume":"42","author":"Nikoloski","year":"2010","journal-title":"Nat Genet"},{"issue":"7","key":"2019111820141320700_B42","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1101\/gad.186411.111","article-title":"A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia.","volume":"26","author":"Simon","year":"2012","journal-title":"Genes Dev"},{"issue":"2","key":"2019111820141320700_B43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.2651","article-title":"Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia.","volume":"18","author":"Ntziachristos","year":"2012","journal-title":"Nat Med"},{"issue":"7380","key":"2019111820141320700_B44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/25\/3914\/1464426\/3914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/25\/3914\/1464426\/3914.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T20:14:32Z","timestamp":1574108072000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/123\/25\/3914\/32877\/A-transgenic-mouse-model-demonstrating-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,19]]},"references-count":44,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2014,6,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-12-473439","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,19]]}}}